All Articles

A young tech brand bets big on a new China factory, aiming to dominate the booming mini PC market by controlling its supply chain and scaling production.

As financial firms battle for top talent, Fisher Investments' 'Great Place to Work' status reveals a new truth: a brand's internal culture is its sharpest edge.

Beyond the Expo's closing gates, Osaka uses a grand parade to transform its main street, proving how strategic cultural events can sustain global momentum.

While rivals chase acquisitions, dsm-firmenich is spending over €1B to buy its own stock. A defensive move or a confident bet on an undervalued future?

NASH Industries' new 'Make in India' motherboard, built with Intel, is more than a product. It's a strategic leap up the tech value chain for a nation.

A new partnership between Land Sterling and Yardi signals a major digital shift in Saudi Arabia's booming real estate market, setting a new standard.

A pivotal industry roundtable in Pune highlights how Indian businesses are tackling net-zero goals and cyber threats as two sides of the same strategic coin.

A pivotal trial shows an Indian-made heart valve performs on par with US leaders, signaling a major disruption in the high-stakes MedTech market.

A luxury hotel in Ishigaki is using a high-tech light show to fight the off-season slump. Is it a brilliant strategy or a threat to a fragile paradise?

NTT DOCOMO is deploying Nokia's AI to manage its 5G network, aiming for Level 4 autonomy, reduced costs, and a new era of operational efficiency.

As Beijing unveils its 15th Five-Year Plan, a strategic pivot to tech self-reliance challenges global investors to look beyond the headlines.

As tourists return to Macao with new spending habits, The St. Regis bets on experiential luxury with a Guerlain-scented festive season. Is this the future?

Co-founder Robert Ortenzio wants to take Select Medical private. We dive into whether his offer is a fair price or an opportunistic play for control.

Align Technology's new jaw-correcting aligner promises teens a comfortable fix for overbites. But do the clinical results match the digital promise?

Kate McAfoose's dual Gold Stevie® wins aren't just personal honors; they signal a market shift towards automation that empowers people and solves real-world crises.

A Chinese biotech's novel bispecific, dual-payload ADCs just secured $60M. Here’s how this new class of therapy aims to outsmart resistant tumors.

As holiday costs rise, platforms like MoneyMutual offer fast cash to those with bad credit. But is this tech-driven access a lifeline or a costly trap?

A new drug from Ascentage Pharma not only shows impressive results in a rare cancer but reveals a novel 'fat-starving' mechanism, boosting its pipeline.

Fidelity's estimated ETF capital gains are out. Beyond the tax headache, these numbers reveal key insights into market performance and fund strategy.

A massive real estate transaction in the San Gabriel Valley reveals a new model for tackling the housing crisis, blending private capital with public good.